Eliksa Therapeutics
Eliksa Therapeutics is a venture-backed biotechnology company with a proprietary cGMP production facility and a robust clinical pipeline addressing unmet medical needs in ocular and cardiovascular indications. Our lead candidate, ELK-003, is a novel multi-target biological modulating inflammation, cell recovery, and tissue healing. ELK-003 has proven to be safe and well-tolerated with human doses without any reported side effects.
7-day free trial · no credit card
Verified contacts
4
available on Kipplo
LinkedIn employees
6
1 to 10 range
Open roles
—
no listings
Distinct roles
4
indexed titles
Tech stack
2
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 4 verified contacts at Eliksa Therapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
4 contacts with verified email or phone · masked until revealed.
- AK
Armen Karamanian
Co-founder & CEO · Other
EmailPhone - VP
Victoria Prieto
Operations Manager · Operations
EmailPhone - BS
Biplav Shrestha
Research Scientist · Research & Development
EmailPhone
Showing 3 of 4 verified contacts
Top roles at Eliksa Therapeutics
4 distinct titles indexed · top 4 shown.
- 1co-founder & ceo
- 1operations manager
- 1research associate
- 1research scientist
Sign up to unlock all 4 contacts at Eliksa Therapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 4 verified contacts at Eliksa Therapeutics
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.